-
Growth course significantly expanded; particularly strong growth in Germany, France and Belgium as well as in key future markets such as Russia, Brazil and India. Sales decline in the United Kingdom, Poland, Mexico, and Indonesia; sales grow in all regions
-
Total revenues increase by 5.1%, operating result more than triples following one-time effects in 2010
-
Improved cost structure and profitability lead to an ROS of 9.3%
-
Brands strengthen further; double-digit sales growth for BION®, KYTTA® and CEBION®
-
Innovative business models such as Intelligent Healthcare Solutions® in Germany and Lamberts Healthcare in the United Kingdom post sales growth of 76% and 6.8%, respectively